Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in ...

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

The Boston-based pharmaceutical company said the Phase 2 trial showed that setmelanotide was effective in reducing body mass index and hyperphagia in patients with Prader-Willi syndrome, a genetic ...

Lilly’s first Phase III results for retatrutide show unprecedented weight loss and marked reductions in osteoarthritis pain, ...

Teenagers who are unhappy with their bodies are more likely to develop symptoms of eating disorders and depression in early adulthood, according to a new study led by University College London (UCL) ...

Investing.com -- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) stock surged 14.9% on Thursday after the company announced positive preliminary results from its Phase 2 trial of setmelanotide in patients ...

An Institute for Value-Based Medicine ® event held in New Haven, Connecticut, on October 30, 2025, brought together a diverse ...

High consumption of ultra-processed foods elevates the risk of early-onset colorectal cancer, highlighting the need for ...

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer .

The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection ...

The strength of an individual’s handgrip was associated with age-related macular degeneration (AMD) in a recent study, with incidence of AMD increasing in those with worse strength. 1 This result ...

Both chole and paneer are versatile, delicious and packed with nutrients, but which one is better for your fitness goals?